
|Videos|July 30, 2020
Dr. Schwartz on Future Research in Sarcoma
Gary K. Schwartz, MD, discusses future research in sarcoma.
Advertisement
Gary K. Schwartz, MD, professor of medicine, chief, Division of Hematology/Oncology, deputy director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, discusses future research in sarcoma.
Despite available data, there is still so much to learn in the sarcoma space, says Schwartz. Most specialistswho treat sarcoma also treat melanoma, leading many to try to determine the nuances of immune response in each disease.
Over the past decade, immunotherapy has revolutionized the melanoma space, transforming the disease into one that can be cured. Unfortunately, in sarcoma, less progress has been made, Schwartz concludes.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas
2
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC
3
Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026
4
Emiltatug Ledadotin Elicits Responses in Aggressive Adenoid Cystic Carcinoma
5








































































